Mamuka Kvaratskhelia
Concepts (413)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Integrase | 36 | 2024 | 70 | 10.430 |
Why?
| HIV-1 | 47 | 2025 | 836 | 10.080 |
Why?
| HIV Integrase Inhibitors | 25 | 2024 | 69 | 8.070 |
Why?
| Virus Integration | 17 | 2022 | 69 | 3.010 |
Why?
| Drug Resistance, Viral | 6 | 2025 | 110 | 2.830 |
Why?
| Anti-HIV Agents | 7 | 2025 | 754 | 2.710 |
Why?
| Virus Replication | 13 | 2025 | 450 | 2.620 |
Why?
| Protein Multimerization | 9 | 2020 | 178 | 2.560 |
Why?
| Intercellular Signaling Peptides and Proteins | 11 | 2021 | 374 | 2.470 |
Why?
| Capsid | 8 | 2025 | 90 | 1.880 |
Why?
| Capsid Proteins | 7 | 2025 | 90 | 1.810 |
Why?
| DNA, Viral | 11 | 2022 | 349 | 1.670 |
Why?
| Protein Binding | 44 | 2025 | 2120 | 1.660 |
Why?
| RNA, Viral | 14 | 2022 | 619 | 1.640 |
Why?
| Virion | 7 | 2022 | 82 | 1.550 |
Why?
| HIV Infections | 19 | 2025 | 2719 | 1.520 |
Why?
| HEK293 Cells | 23 | 2025 | 696 | 1.330 |
Why?
| Integrases | 6 | 2017 | 119 | 1.170 |
Why?
| Virus Assembly | 6 | 2025 | 76 | 1.170 |
Why?
| Acetamides | 2 | 2025 | 36 | 1.150 |
Why?
| Indazoles | 2 | 2025 | 66 | 1.140 |
Why?
| Leukemia Virus, Murine | 4 | 2016 | 17 | 1.110 |
Why?
| Allosteric Regulation | 13 | 2023 | 99 | 1.030 |
Why?
| Gene Products, gag | 4 | 2018 | 36 | 1.030 |
Why?
| Models, Molecular | 24 | 2025 | 1487 | 1.000 |
Why?
| Mass Spectrometry | 15 | 2017 | 713 | 0.980 |
Why?
| Antiviral Agents | 6 | 2024 | 712 | 0.970 |
Why?
| Endodeoxyribonucleases | 8 | 2001 | 67 | 0.950 |
Why?
| Human T-lymphotropic virus 1 | 7 | 2023 | 28 | 0.930 |
Why?
| Nucleosomes | 3 | 2022 | 137 | 0.920 |
Why?
| Pyridines | 2 | 2019 | 478 | 0.920 |
Why?
| Acetates | 3 | 2014 | 100 | 0.900 |
Why?
| Pyrazines | 1 | 2025 | 86 | 0.900 |
Why?
| HIV Reverse Transcriptase | 7 | 2019 | 30 | 0.880 |
Why?
| Nuclear Pore Complex Proteins | 5 | 2025 | 36 | 0.860 |
Why?
| Mutation, Missense | 3 | 2014 | 317 | 0.860 |
Why?
| Genome, Viral | 4 | 2021 | 128 | 0.830 |
Why?
| Prions | 1 | 2022 | 46 | 0.780 |
Why?
| Nuclear Proteins | 5 | 2016 | 659 | 0.780 |
Why?
| Transcription Factors | 7 | 2017 | 1647 | 0.760 |
Why?
| HIV Seropositivity | 1 | 2022 | 119 | 0.760 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 2014 | 136 | 0.750 |
Why?
| Crystallography, X-Ray | 7 | 2025 | 435 | 0.700 |
Why?
| Protein Conformation | 14 | 2025 | 861 | 0.700 |
Why?
| Vesicular Transport Proteins | 1 | 2021 | 84 | 0.680 |
Why?
| Protein Structure, Tertiary | 14 | 2016 | 841 | 0.580 |
Why?
| Gene Products, pol | 1 | 2017 | 6 | 0.570 |
Why?
| Sulfolobus | 7 | 2001 | 11 | 0.570 |
Why?
| Quinolines | 3 | 2014 | 156 | 0.550 |
Why?
| DNA | 13 | 2014 | 1396 | 0.550 |
Why?
| Humans | 65 | 2025 | 129266 | 0.530 |
Why?
| Protein Interaction Domains and Motifs | 6 | 2019 | 138 | 0.520 |
Why?
| Archaeal Proteins | 3 | 2001 | 49 | 0.520 |
Why?
| Binding Sites | 15 | 2021 | 1250 | 0.510 |
Why?
| Amino Acid Sequence | 19 | 2019 | 2056 | 0.500 |
Why?
| Recombinant Proteins | 6 | 2013 | 1304 | 0.490 |
Why?
| Recombination, Genetic | 6 | 2001 | 190 | 0.490 |
Why?
| Protein Footprinting | 6 | 2011 | 11 | 0.460 |
Why?
| Molecular Sequence Data | 19 | 2015 | 2835 | 0.460 |
Why?
| Moloney murine leukemia virus | 1 | 2014 | 13 | 0.460 |
Why?
| HeLa Cells | 5 | 2020 | 611 | 0.450 |
Why?
| Myxovirus Resistance Proteins | 3 | 2025 | 13 | 0.450 |
Why?
| Transcription Initiation Site | 2 | 2014 | 43 | 0.450 |
Why?
| Viral Proteins | 5 | 2016 | 327 | 0.430 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 227 | 0.420 |
Why?
| Cell Cycle Proteins | 6 | 2017 | 584 | 0.420 |
Why?
| Cell Line | 12 | 2025 | 2779 | 0.420 |
Why?
| Nucleic Acid Conformation | 9 | 2021 | 706 | 0.410 |
Why?
| Protein Domains | 5 | 2025 | 253 | 0.410 |
Why?
| beta Karyopherins | 1 | 2012 | 7 | 0.400 |
Why?
| Host-Pathogen Interactions | 5 | 2021 | 351 | 0.400 |
Why?
| Integrase Inhibitors | 1 | 2012 | 1 | 0.390 |
Why?
| mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 27 | 0.380 |
Why?
| Avian Leukosis Virus | 2 | 2017 | 6 | 0.370 |
Why?
| Indoles | 1 | 2014 | 384 | 0.370 |
Why?
| RNA, Transfer | 2 | 2016 | 130 | 0.360 |
Why?
| Mutation | 8 | 2025 | 3710 | 0.350 |
Why?
| Archaea | 2 | 2001 | 78 | 0.350 |
Why?
| Catalytic Domain | 8 | 2016 | 218 | 0.340 |
Why?
| Nuclear Pore | 2 | 2021 | 16 | 0.330 |
Why?
| Proteins | 4 | 2020 | 941 | 0.330 |
Why?
| Viral Nonstructural Proteins | 3 | 2016 | 58 | 0.320 |
Why?
| Peptides | 5 | 2018 | 923 | 0.320 |
Why?
| Gene Products, tax | 3 | 2019 | 13 | 0.320 |
Why?
| DNA Footprinting | 1 | 2008 | 33 | 0.310 |
Why?
| RNA-Binding Proteins | 4 | 2018 | 387 | 0.300 |
Why?
| Structure-Activity Relationship | 5 | 2021 | 548 | 0.300 |
Why?
| DNA-Binding Proteins | 9 | 2017 | 1446 | 0.290 |
Why?
| Hepacivirus | 3 | 2016 | 235 | 0.290 |
Why?
| Histones | 3 | 2022 | 588 | 0.280 |
Why?
| Salicylates | 2 | 2016 | 30 | 0.270 |
Why?
| Cytoplasm | 2 | 2021 | 265 | 0.270 |
Why?
| Molecular Dynamics Simulation | 2 | 2020 | 217 | 0.260 |
Why?
| Electrophoresis, Polyacrylamide Gel | 6 | 2008 | 327 | 0.260 |
Why?
| Amino Acid Motifs | 4 | 2021 | 213 | 0.250 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 31 | 0.250 |
Why?
| Active Transport, Cell Nucleus | 3 | 2025 | 113 | 0.250 |
Why?
| Holliday Junction Resolvases | 8 | 2001 | 8 | 0.250 |
Why?
| DNA Damage | 4 | 2021 | 383 | 0.250 |
Why?
| Lysine | 8 | 2022 | 286 | 0.250 |
Why?
| Basic-Leucine Zipper Transcription Factors | 2 | 2017 | 41 | 0.250 |
Why?
| Ribonuclease H, Human Immunodeficiency Virus | 2 | 2019 | 2 | 0.240 |
Why?
| Pyridoxal Phosphate | 1 | 2004 | 21 | 0.230 |
Why?
| Avian Sarcoma Viruses | 1 | 2004 | 4 | 0.230 |
Why?
| Aptamers, Nucleotide | 2 | 2018 | 77 | 0.230 |
Why?
| Cyclophilins | 1 | 2025 | 41 | 0.230 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 66 | 0.220 |
Why?
| Biotin | 2 | 2005 | 23 | 0.220 |
Why?
| Protein Processing, Post-Translational | 3 | 2017 | 454 | 0.220 |
Why?
| Viral Envelope Proteins | 1 | 2004 | 81 | 0.220 |
Why?
| Y-Box-Binding Protein 1 | 1 | 2023 | 5 | 0.220 |
Why?
| Molecular Chaperones | 1 | 2025 | 182 | 0.210 |
Why?
| Magnesium | 3 | 2000 | 153 | 0.210 |
Why?
| Receptors, Virus | 2 | 2019 | 83 | 0.210 |
Why?
| Cell Nucleus | 2 | 2021 | 586 | 0.210 |
Why?
| Chromatography, Gel | 4 | 2009 | 126 | 0.210 |
Why?
| RNA, Transfer, Lys | 1 | 2002 | 2 | 0.210 |
Why?
| Succinimides | 1 | 2002 | 17 | 0.210 |
Why?
| Protein Structure, Quaternary | 4 | 2008 | 122 | 0.200 |
Why?
| Mutagenesis, Site-Directed | 6 | 2009 | 361 | 0.200 |
Why?
| Xeroderma Pigmentosum Group A Protein | 2 | 2014 | 5 | 0.200 |
Why?
| Chromosomes, Human | 1 | 2022 | 41 | 0.200 |
Why?
| Molecular Docking Simulation | 3 | 2019 | 109 | 0.200 |
Why?
| Histone Code | 1 | 2022 | 31 | 0.200 |
Why?
| Drugs, Investigational | 1 | 2022 | 32 | 0.200 |
Why?
| Oligonucleotides | 3 | 2018 | 140 | 0.200 |
Why?
| Carboxylic Acids | 2 | 2019 | 32 | 0.200 |
Why?
| Phenylalanine | 1 | 2022 | 65 | 0.200 |
Why?
| Thiophenes | 2 | 2016 | 117 | 0.200 |
Why?
| Protein Subunits | 2 | 2015 | 234 | 0.190 |
Why?
| Cryoelectron Microscopy | 2 | 2020 | 177 | 0.190 |
Why?
| Proteolysis | 3 | 2017 | 167 | 0.190 |
Why?
| Drug Discovery | 3 | 2019 | 131 | 0.190 |
Why?
| Viral Core Proteins | 2 | 2012 | 21 | 0.190 |
Why?
| Cyclophilin A | 2 | 2024 | 26 | 0.190 |
Why?
| Glycine | 1 | 2022 | 165 | 0.190 |
Why?
| HTLV-I Infections | 4 | 2019 | 22 | 0.180 |
Why?
| Chromatin | 2 | 2022 | 478 | 0.180 |
Why?
| Peroxidases | 2 | 1999 | 33 | 0.180 |
Why?
| RNA | 1 | 2008 | 880 | 0.180 |
Why?
| Reverse Transcription | 1 | 2021 | 18 | 0.180 |
Why?
| Lentiviruses, Primate | 1 | 2021 | 13 | 0.180 |
Why?
| Isoenzymes | 3 | 1999 | 302 | 0.180 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 42 | 0.180 |
Why?
| Purines | 1 | 2002 | 172 | 0.180 |
Why?
| Deuterium Exchange Measurement | 1 | 2020 | 29 | 0.180 |
Why?
| Tea | 2 | 1997 | 20 | 0.180 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 827 | 0.170 |
Why?
| Cross-Linking Reagents | 2 | 2016 | 205 | 0.170 |
Why?
| Manganese | 2 | 1999 | 59 | 0.170 |
Why?
| Necrosis | 1 | 2021 | 232 | 0.170 |
Why?
| Base Sequence | 7 | 2016 | 2146 | 0.170 |
Why?
| Retroviridae Proteins | 2 | 2017 | 11 | 0.170 |
Why?
| Neuroblastoma | 1 | 2021 | 151 | 0.170 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 399 | 0.160 |
Why?
| Reverse Transcriptase Inhibitors | 2 | 2011 | 83 | 0.160 |
Why?
| Amino Acid Substitution | 2 | 2013 | 282 | 0.160 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 2000 | 383 | 0.160 |
Why?
| Stereoisomerism | 1 | 2019 | 97 | 0.160 |
Why?
| Protein Interaction Mapping | 3 | 2012 | 108 | 0.150 |
Why?
| Glucose Transporter Type 1 | 1 | 2019 | 49 | 0.150 |
Why?
| Amino Acids | 1 | 2022 | 486 | 0.150 |
Why?
| Gene Products, vpr | 1 | 2018 | 1 | 0.150 |
Why?
| Glycerol | 1 | 2018 | 91 | 0.150 |
Why?
| Substrate Specificity | 4 | 2016 | 368 | 0.140 |
Why?
| Protein Folding | 2 | 2016 | 264 | 0.140 |
Why?
| Surface Plasmon Resonance | 1 | 2017 | 88 | 0.140 |
Why?
| High Mobility Group Proteins | 1 | 2017 | 42 | 0.140 |
Why?
| Immunoblotting | 2 | 2016 | 305 | 0.130 |
Why?
| Transcriptional Elongation Factors | 1 | 2017 | 36 | 0.130 |
Why?
| Peroxidase | 1 | 1997 | 174 | 0.130 |
Why?
| 5' Untranslated Regions | 2 | 2021 | 55 | 0.130 |
Why?
| meta-Aminobenzoates | 1 | 2016 | 1 | 0.130 |
Why?
| alpha-Defensins | 1 | 2016 | 10 | 0.130 |
Why?
| Nucleocapsid | 1 | 2016 | 18 | 0.130 |
Why?
| Adenosine | 1 | 2018 | 227 | 0.130 |
Why?
| Protein Structure, Secondary | 3 | 2008 | 340 | 0.130 |
Why?
| Mutant Proteins | 2 | 2014 | 99 | 0.130 |
Why?
| DNA Packaging | 1 | 2016 | 24 | 0.130 |
Why?
| Ribonuclease P | 1 | 2016 | 25 | 0.130 |
Why?
| Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 186 | 0.130 |
Why?
| DNA, Single-Stranded | 3 | 2006 | 114 | 0.130 |
Why?
| Dynamic Light Scattering | 1 | 2016 | 7 | 0.130 |
Why?
| Nucleic Acids | 1 | 2016 | 60 | 0.130 |
Why?
| Calcium | 2 | 2021 | 1212 | 0.120 |
Why?
| Morphogenesis | 1 | 2016 | 158 | 0.120 |
Why?
| Drug Design | 1 | 2016 | 156 | 0.120 |
Why?
| NIH 3T3 Cells | 2 | 2013 | 140 | 0.120 |
Why?
| Spectrometry, Fluorescence | 1 | 2016 | 163 | 0.120 |
Why?
| Sequence Homology, Amino Acid | 5 | 2005 | 372 | 0.120 |
Why?
| Models, Chemical | 1 | 2016 | 263 | 0.120 |
Why?
| Biotinylation | 2 | 2006 | 29 | 0.120 |
Why?
| Histidine | 1 | 2014 | 60 | 0.120 |
Why?
| Microbial Sensitivity Tests | 1 | 2016 | 350 | 0.110 |
Why?
| Escherichia coli | 4 | 2007 | 766 | 0.110 |
Why?
| Animals | 12 | 2021 | 35309 | 0.110 |
Why?
| Gene Knockout Techniques | 1 | 2014 | 109 | 0.110 |
Why?
| Hepatitis C | 1 | 2016 | 238 | 0.110 |
Why?
| DNA Repair | 2 | 2009 | 206 | 0.110 |
Why?
| Circular Dichroism | 2 | 2012 | 147 | 0.110 |
Why?
| Nucleoproteins | 2 | 2017 | 28 | 0.110 |
Why?
| Peptide Mapping | 2 | 2007 | 63 | 0.110 |
Why?
| Carrier Proteins | 1 | 2017 | 742 | 0.100 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2014 | 485 | 0.100 |
Why?
| Hydrolysis | 3 | 2007 | 186 | 0.100 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 431 | 0.100 |
Why?
| Genetic Vectors | 1 | 2014 | 312 | 0.100 |
Why?
| Chromatin Immunoprecipitation | 1 | 2013 | 132 | 0.100 |
Why?
| Azepines | 1 | 2013 | 88 | 0.100 |
Why?
| Human T-lymphotropic virus 2 | 1 | 2012 | 1 | 0.100 |
Why?
| HTLV-II Infections | 1 | 2012 | 2 | 0.100 |
Why?
| Gene Expression Regulation, Viral | 3 | 2021 | 90 | 0.100 |
Why?
| Scattering, Small Angle | 1 | 2012 | 20 | 0.100 |
Why?
| Thermodynamics | 3 | 2020 | 406 | 0.100 |
Why?
| Genetic Therapy | 1 | 2014 | 288 | 0.100 |
Why?
| Indoleacetic Acids | 1 | 2012 | 9 | 0.100 |
Why?
| X-Ray Diffraction | 1 | 2012 | 94 | 0.100 |
Why?
| Calorimetry | 3 | 2001 | 66 | 0.100 |
Why?
| Cell Line, Tumor | 2 | 2013 | 3202 | 0.100 |
Why?
| Triazoles | 1 | 2013 | 151 | 0.090 |
Why?
| Potassium Permanganate | 2 | 2002 | 3 | 0.090 |
Why?
| RNA Interference | 1 | 2013 | 450 | 0.090 |
Why?
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 13 | 0.090 |
Why?
| Virology | 1 | 2010 | 23 | 0.090 |
Why?
| Nerve Tissue Proteins | 1 | 2014 | 569 | 0.090 |
Why?
| DEAD-box RNA Helicases | 1 | 2010 | 66 | 0.080 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2011 | 148 | 0.080 |
Why?
| Kinetics | 4 | 2009 | 1644 | 0.080 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 175 | 0.080 |
Why?
| DNA Polymerase beta | 1 | 2009 | 5 | 0.080 |
Why?
| Ribonuclease H | 3 | 2007 | 12 | 0.080 |
Why?
| Cloning, Molecular | 2 | 2000 | 525 | 0.080 |
Why?
| Furans | 1 | 2008 | 23 | 0.080 |
Why?
| Tumor Suppressor Proteins | 1 | 2011 | 314 | 0.070 |
Why?
| Protein Biosynthesis | 1 | 2010 | 405 | 0.070 |
Why?
| Urea | 1 | 2008 | 76 | 0.070 |
Why?
| Models, Biological | 3 | 2019 | 1722 | 0.070 |
Why?
| Conserved Sequence | 2 | 2017 | 227 | 0.070 |
Why?
| Autoantigens | 1 | 2011 | 419 | 0.070 |
Why?
| Nuclear Lamina | 1 | 2007 | 10 | 0.070 |
Why?
| Neoplasm Proteins | 1 | 2010 | 422 | 0.070 |
Why?
| Macromolecular Substances | 2 | 2010 | 216 | 0.070 |
Why?
| Retroviridae | 2 | 2010 | 99 | 0.070 |
Why?
| Multiprotein Complexes | 2 | 2011 | 155 | 0.070 |
Why?
| Proteomics | 1 | 2013 | 1054 | 0.070 |
Why?
| RNA, Small Interfering | 2 | 2023 | 591 | 0.070 |
Why?
| RNA Splicing | 2 | 2015 | 260 | 0.070 |
Why?
| Ultraviolet Rays | 1 | 2009 | 382 | 0.070 |
Why?
| Phytic Acid | 1 | 2006 | 43 | 0.070 |
Why?
| Ribonucleoproteins | 2 | 2020 | 87 | 0.060 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2006 | 77 | 0.060 |
Why?
| Electron Spin Resonance Spectroscopy | 3 | 1999 | 91 | 0.060 |
Why?
| Phosphorylation | 3 | 2021 | 1710 | 0.060 |
Why?
| Inhibitory Concentration 50 | 1 | 2004 | 86 | 0.060 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2004 | 8 | 0.060 |
Why?
| Viral Fusion Proteins | 1 | 2004 | 18 | 0.060 |
Why?
| Calreticulin | 1 | 2004 | 27 | 0.060 |
Why?
| Avian Proteins | 1 | 2004 | 21 | 0.060 |
Why?
| Carbohydrate Metabolism | 1 | 2004 | 62 | 0.060 |
Why?
| Carbohydrates | 1 | 2004 | 64 | 0.060 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2010 | 1056 | 0.060 |
Why?
| Glycosylation | 1 | 2004 | 152 | 0.060 |
Why?
| Dimerization | 4 | 2007 | 191 | 0.060 |
Why?
| Chickens | 1 | 2004 | 189 | 0.060 |
Why?
| CRISPR-Cas Systems | 1 | 2025 | 108 | 0.050 |
Why?
| Terminal Repeat Sequences | 1 | 2023 | 15 | 0.050 |
Why?
| Oxidation-Reduction | 2 | 1997 | 1028 | 0.050 |
Why?
| GTP Phosphohydrolases | 1 | 2024 | 85 | 0.050 |
Why?
| Genes, Viral | 1 | 2023 | 82 | 0.050 |
Why?
| Oxazines | 1 | 2023 | 27 | 0.050 |
Why?
| Thymine | 1 | 2003 | 13 | 0.050 |
Why?
| RNA-Directed DNA Polymerase | 1 | 2003 | 34 | 0.050 |
Why?
| Acetylation | 1 | 2004 | 244 | 0.050 |
Why?
| DNA, Fungal | 1 | 2003 | 75 | 0.050 |
Why?
| Retroelements | 1 | 2003 | 44 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2002 | 109 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 947 | 0.050 |
Why?
| Mice | 4 | 2013 | 16915 | 0.050 |
Why?
| Aspartic Acid | 1 | 2022 | 80 | 0.050 |
Why?
| Base Pair Mismatch | 1 | 2002 | 11 | 0.050 |
Why?
| Static Electricity | 1 | 2022 | 116 | 0.050 |
Why?
| Pyrococcus | 1 | 2001 | 1 | 0.050 |
Why?
| Nucleocapsid Proteins | 1 | 2021 | 25 | 0.050 |
Why?
| DNA Primers | 2 | 2000 | 510 | 0.050 |
Why?
| Methylation | 1 | 2022 | 230 | 0.050 |
Why?
| Fluorescence Polarization | 1 | 2001 | 38 | 0.050 |
Why?
| Pyrococcus furiosus | 1 | 2001 | 3 | 0.050 |
Why?
| Chromatography | 1 | 2001 | 25 | 0.050 |
Why?
| Enzyme Stability | 2 | 1999 | 69 | 0.050 |
Why?
| Membrane Proteins | 1 | 2007 | 1117 | 0.040 |
Why?
| Entropy | 1 | 2020 | 39 | 0.040 |
Why?
| Genes, Archaeal | 1 | 2000 | 6 | 0.040 |
Why?
| Candida albicans | 1 | 2000 | 53 | 0.040 |
Why?
| Time Factors | 2 | 2001 | 6543 | 0.040 |
Why?
| Peptide Fragments | 1 | 2004 | 692 | 0.040 |
Why?
| Dogs | 1 | 2021 | 382 | 0.040 |
Why?
| DNA, Archaeal | 1 | 2000 | 15 | 0.040 |
Why?
| Cations, Divalent | 1 | 1999 | 54 | 0.040 |
Why?
| Phosphoglycerate Mutase | 1 | 1999 | 1 | 0.040 |
Why?
| Open Reading Frames | 1 | 2000 | 116 | 0.040 |
Why?
| Sequence Alignment | 1 | 2000 | 332 | 0.040 |
Why?
| Saccharomyces cerevisiae | 2 | 2003 | 530 | 0.040 |
Why?
| PDZ Domains | 1 | 2019 | 4 | 0.040 |
Why?
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 11 | 0.040 |
Why?
| Sorting Nexins | 1 | 2019 | 10 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2021 | 942 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2023 | 1204 | 0.040 |
Why?
| G-Quadruplexes | 1 | 2018 | 17 | 0.040 |
Why?
| Lipids | 1 | 2022 | 625 | 0.040 |
Why?
| Virus Internalization | 1 | 2018 | 47 | 0.040 |
Why?
| Molecular Structure | 1 | 2019 | 481 | 0.040 |
Why?
| Reactive Oxygen Species | 1 | 2021 | 596 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2019 | 316 | 0.040 |
Why?
| Virulence | 1 | 2019 | 255 | 0.040 |
Why?
| Ascorbate Peroxidases | 1 | 1997 | 2 | 0.040 |
Why?
| Salicylic Acid | 1 | 1997 | 9 | 0.040 |
Why?
| Transfection | 2 | 2012 | 915 | 0.040 |
Why?
| Tripartite Motif Proteins | 1 | 2017 | 29 | 0.040 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 1997 | 84 | 0.030 |
Why?
| Cricetulus | 1 | 2017 | 108 | 0.030 |
Why?
| Point Mutation | 2 | 2009 | 224 | 0.030 |
Why?
| CHO Cells | 1 | 2017 | 154 | 0.030 |
Why?
| Genomics | 1 | 2022 | 717 | 0.030 |
Why?
| Hot Temperature | 1 | 2000 | 369 | 0.030 |
Why?
| Gene Products, rex | 1 | 2017 | 1 | 0.030 |
Why?
| Molecular Weight | 1 | 1997 | 328 | 0.030 |
Why?
| Plant Proteins | 1 | 1997 | 89 | 0.030 |
Why?
| Chick Embryo | 1 | 2017 | 130 | 0.030 |
Why?
| Potyvirus | 1 | 2016 | 1 | 0.030 |
Why?
| Simian foamy virus | 1 | 2016 | 3 | 0.030 |
Why?
| Cell Survival | 2 | 2011 | 1075 | 0.030 |
Why?
| beta-Defensins | 1 | 2016 | 20 | 0.030 |
Why?
| DNA Viruses | 1 | 2016 | 11 | 0.030 |
Why?
| Chemical Precipitation | 1 | 2016 | 37 | 0.030 |
Why?
| Acyltransferases | 1 | 2017 | 55 | 0.030 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2016 | 13 | 0.030 |
Why?
| Protein Unfolding | 1 | 2016 | 31 | 0.030 |
Why?
| Molecular Motor Proteins | 1 | 2016 | 35 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2018 | 538 | 0.030 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 154 | 0.030 |
Why?
| Protein Stability | 1 | 2016 | 162 | 0.030 |
Why?
| Molecular Conformation | 1 | 2016 | 144 | 0.030 |
Why?
| Rats, Sprague-Dawley | 1 | 2021 | 2396 | 0.030 |
Why?
| DNA Helicases | 1 | 2016 | 149 | 0.030 |
Why?
| Signal Transduction | 2 | 2021 | 4926 | 0.030 |
Why?
| Introns | 1 | 2015 | 251 | 0.030 |
Why?
| Arginine | 2 | 2007 | 265 | 0.030 |
Why?
| Oxidative Stress | 1 | 2021 | 1266 | 0.030 |
Why?
| Enzyme Activation | 1 | 2015 | 812 | 0.030 |
Why?
| CpG Islands | 1 | 2014 | 152 | 0.030 |
Why?
| Sequence Deletion | 1 | 2014 | 179 | 0.030 |
Why?
| Genetic Variation | 1 | 2018 | 938 | 0.030 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2012 | 5 | 0.030 |
Why?
| Cell Transformation, Viral | 1 | 2012 | 27 | 0.030 |
Why?
| Rats | 1 | 2021 | 5482 | 0.020 |
Why?
| Chromatography, Affinity | 1 | 2012 | 83 | 0.020 |
Why?
| Mice, Knockout | 2 | 2012 | 2871 | 0.020 |
Why?
| Protein-Arginine N-Methyltransferases | 1 | 2012 | 28 | 0.020 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 257 | 0.020 |
Why?
| Tandem Mass Spectrometry | 1 | 2015 | 523 | 0.020 |
Why?
| Apoptosis | 1 | 2021 | 2499 | 0.020 |
Why?
| Phenotype | 1 | 2020 | 3074 | 0.020 |
Why?
| Genotype | 1 | 2016 | 1835 | 0.020 |
Why?
| NF-kappa B | 1 | 2015 | 665 | 0.020 |
Why?
| G2 Phase | 1 | 2011 | 36 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2014 | 776 | 0.020 |
Why?
| Jurkat Cells | 1 | 2011 | 134 | 0.020 |
Why?
| Hydroxyl Radical | 1 | 2011 | 91 | 0.020 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2010 | 53 | 0.020 |
Why?
| Cell Division | 1 | 2011 | 796 | 0.020 |
Why?
| Combinatorial Chemistry Techniques | 1 | 2008 | 16 | 0.020 |
Why?
| Nucleotides | 1 | 2009 | 122 | 0.020 |
Why?
| Fibroblasts | 1 | 2012 | 948 | 0.020 |
Why?
| Lamin Type A | 1 | 2007 | 48 | 0.020 |
Why?
| Tritium | 1 | 2006 | 75 | 0.020 |
Why?
| Schiff Bases | 1 | 2006 | 7 | 0.020 |
Why?
| 5-Hydroxytryptophan | 1 | 2006 | 20 | 0.020 |
Why?
| DNA Topoisomerases, Type I | 1 | 2006 | 14 | 0.020 |
Why?
| Solutions | 1 | 2006 | 150 | 0.020 |
Why?
| Palmitic Acids | 1 | 2005 | 9 | 0.020 |
Why?
| Chymotrypsin | 1 | 2005 | 19 | 0.020 |
Why?
| Subcellular Fractions | 1 | 2005 | 80 | 0.020 |
Why?
| Replication Protein A | 1 | 2005 | 12 | 0.010 |
Why?
| Embryo, Mammalian | 1 | 2005 | 224 | 0.010 |
Why?
| Plasmids | 1 | 2005 | 358 | 0.010 |
Why?
| Microscopy, Confocal | 1 | 2005 | 305 | 0.010 |
Why?
| Tryptophan | 1 | 2005 | 178 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 2005 | 398 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 360 | 0.010 |
Why?
| RNA, Fungal | 1 | 2003 | 67 | 0.010 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2003 | 87 | 0.010 |
Why?
| Fluorometry | 1 | 2001 | 17 | 0.010 |
Why?
| Carbocyanines | 1 | 2001 | 33 | 0.010 |
Why?
| Fluorescein | 1 | 2001 | 24 | 0.010 |
Why?
| Cell Membrane | 1 | 2005 | 733 | 0.010 |
Why?
| Energy Transfer | 1 | 2001 | 50 | 0.010 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2001 | 83 | 0.010 |
Why?
| Stem Cells | 1 | 2005 | 574 | 0.010 |
Why?
| Enzyme Reactivators | 1 | 1999 | 2 | 0.010 |
Why?
| Phanerochaete | 1 | 1999 | 3 | 0.010 |
Why?
| Escherichia coli Proteins | 1 | 2001 | 178 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 2001 | 312 | 0.010 |
Why?
| Spectrophotometry | 1 | 1999 | 57 | 0.010 |
Why?
| Vanadates | 1 | 1999 | 14 | 0.010 |
Why?
| RNA Stability | 1 | 2000 | 102 | 0.010 |
Why?
| Heme | 1 | 1999 | 77 | 0.010 |
Why?
| Genes, Bacterial | 1 | 1999 | 157 | 0.010 |
Why?
| Ligands | 1 | 2000 | 621 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 1999 | 541 | 0.010 |
Why?
| Mitochondrial Proteins | 1 | 2000 | 248 | 0.010 |
Why?
| Temperature | 1 | 1999 | 634 | 0.010 |
Why?
| Bacterial Proteins | 1 | 2001 | 833 | 0.010 |
Why?
| Gene Expression | 1 | 1999 | 1466 | 0.010 |
Why?
|
|
Kvaratskhelia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|